@njx58 indeed!

For this study - Combined Anabolic Therapy (CAT):

Inclusion Criteria:

women aged 45+
postmenopausal
osteoporotic with high risk of fracture

Exclusion Criteria:

no significant previous use of bone health modifying treatments
known congenital or acquired bone disease other than osteoporosis
significant renal disease, liver disease, cardiopulmonary disease, or psychiatric disease
abnormal calcium or parathyroid hormone level
serum vitamin D <20 ng/dL
anemia (hematocrit <32%)
history of malignancy (except non-melanoma skin carcinoma)
excessive alcohol use or substance abuse
known contraindications to romosozumab or teriparatide

information provided by Dr. Benjamin Leder and is available on ClinicalTrials.gov ID NCT06558188